Gossamer Bio to Announce Fourth Quarter & Full-Year 2020 Financial Results & Host Conference Call & Webcast on February 25, 2...
February 19 2021 - 8:01AM
Business Wire
Gossamer Bio, Inc. (Nasdaq: GOSS), a clinical-stage
biopharmaceutical company focused on discovering, acquiring,
developing and commercializing therapeutics in the disease areas of
immunology, inflammation and oncology, today announced that it will
report its fourth quarter and full-year 2020 financial results on
Thursday, February 25, 2021.
In connection with the earnings release, Gossamer’s management
team will host a live conference call and webcast at 8:30 a.m. ET
on Thursday, February 25, 2021, to discuss the Company’s financial
results and provide a corporate update.
Conference ID: 5764004 Domestic Dial-in Number: (833) 646-0603
International Dial-in Number: (929) 517-9782 Live Webcast:
https://edge.media-server.com/mmc/p/vsbk8uqe
A replay of the audio webcast will be available for 30 days on
the Investors section of the Company's website,
www.gossamerbio.com.
About Gossamer Bio
Gossamer Bio is a clinical-stage biopharmaceutical company
focused on discovering, acquiring, developing and commercializing
therapeutics in the disease areas of immunology, inflammation and
oncology. Its goal is to be an industry leader in each of these
therapeutic areas and to enhance and extend the lives of patients
suffering from such diseases.
View source
version on businesswire.com: https://www.businesswire.com/news/home/20210219005072/en/
For Investors and Media: Bryan Giraudo, Chief Financial
Officer Gossamer Bio Investor Relations ir@gossamerbio.com
Gossamer Bio (NASDAQ:GOSS)
Historical Stock Chart
From Aug 2024 to Sep 2024
Gossamer Bio (NASDAQ:GOSS)
Historical Stock Chart
From Sep 2023 to Sep 2024